Search results
NKGen Biotech gears up for Parkinson's trial after FDA nod By Investing.com
Investing.com· 5 days agoNKGen Biotech, Inc. (NASDAQ: NKGN), a clinical-stage biotech company, has received clearance from...
Stock Market Crash Warning: Don't Get Caught Holding These 3 Biotech Stocks
InvestorPlace· 4 days agoInvesting in the biotech sphere isn’t for the faint of heart, and you should steer clear of the ...
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
InvestorPlace· 4 days agoBiotech stocks offer the opportunity to invest in life-saving treatments and drugs. If you want to ...
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
Motley Fool via Yahoo Finance· 2 days agoWith a pipeline that carries several dozen programs, the company should deliver plenty of regulatory...
Janux Therapeutics (JANX) stock has gone parabolic: what next? | Invezz
Invezz· 5 days agoJanux Therapeutics (NASDAQ: JANX) stock price has gone vertical this year, making it one of the...
Mather Group LLC. Has $292,000 Position in The Clorox Company (NYSE:CLX)
ETF DAILY NEWS· 2 days agoThe fund owned 2,049 shares of the company’s stock after selling 747 shares during the quarter....
Biotech Stock Catapults 73% On Its $2.4 Billion Takeover
Investor's Business Daily· 5 days agoDoing so allows for more accurate and complete inhibition, Deciphera says. Piper Sandler analyst...
Headlands Technologies LLC Acquires 3,863 Shares of Direxion Daily S&P Biotech Bear 3x Shares...
ETF DAILY NEWS· 5 days agoHeadlands Technologies LLC boosted its holdings in shares of Direxion Daily S&P Biotech Bear 3x...
Stoke therapeutics CMO sells $113,653 in stock By Investing.com
Investing.com· 1 day agoThe sale involved 10,000 shares of Stoke Therapeutics common stock at weighted average prices...
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street's Radar
InvestorPlace· 1 day agoGene editing stocks are among the most intriguing in the biotech scene. The genomics revolution may...